home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Diagnosis And Treatment Insights For An Unusual Childhood Cancer Syndrome

 
  February, 7 2007 9:40
your information resource in human molecular genetics
 
     
An unusual case of a young girl with a colon cancer syndrome caused by recessive mutations in the mismatch repair gene MSH6 is described in the February 2007 issue of Nature Clinical Practice Oncology. Individuals with mutations in MSH6 are at an increased risk of developing cancer; however, a childhood cancer syndrome caused by these mutations has only recently been recognized.

In this article, Richard Scott and colleagues report how a 13-year-old girl who was treated for a brain tumor and leukemia was subsequently diagnosed with multiple colon cancers and skin lesions, despite an absence of hereditary colon cancer. Recessive mutations in the MSH6 gene were identified in this patient and she was successfully treated with surgery and chemotherapy.

This case study broadens the tumor spectrum associated with recessive MSH6 mutations and discusses the implications for treatment in such individuals. Many mismatch repair deficiency syndromes are treated with the drug temozolomide, but preclinical and clinical data show that it can cause resistance and may promote further genetic abnormality. Mutations in MSH6 and other mismatch repair genes should be considered in any child presenting with malignancy and abnormal skin pigmentation. Early diagnosis is important so that genetic testing and screening can be offered to relatives, and could also help avoid ineffective chemotherapeutic agents such as temozolomide.

Author contact details:

Richard Scott (Section of Cancer Genetics, Institute of Cancer Research, Surrey, UK)
Email: richard.scott@icr.ac.uk

Editor contact

Lisa Hutchinson (Editor, Nature Clinical Practice Oncology)
Email: l.hutchinson@nature.com

Abstract available online.

(C) Nature Clinical Practice Oncology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.